<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/jcb/journal/vaop/ncurrent/rss.rdf">
<title>Journal of Commercial Biotechnology</title>
<description/>
<link>http://www.nature.com/jcb/journal/vaop/ncurrent/rss.rdf</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>Copyright &#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:issn>1462-8732</prism:issn>
<prism:copyright>Copyright &#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/jcb.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050074"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050078"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050073"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050072"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050076"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050077"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050079"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050080"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050081"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050082"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/palgrave.jcb.3050075"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/jcb.gif">
<title>Journal of Commercial Biotechnology</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/jcb.gif</url>
<link>http://www.nature.com/jcb/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050074">
<title>Editorial</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050074</link>
<dc:title>Editorial</dc:title>
<dc:creator>Yali Friedman</dc:creator>
<dc:identifier>doi:10.1057/palgrave.jcb.3050074</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 1 ()</dc:source>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>1</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050078">
<title>Bioentrepreneurship education programmes in the United States</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050078</link>
<dc:title>Bioentrepreneurship education programmes in the United States</dc:title>
<dc:creator>Arlen D Meyers</dc:creator>
<dc:creator>Patrick Hurley</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050078</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 2 ()</dc:source>
<dc:date>November 27, 2007</dc:date>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:publicationDate>November 27, 2007</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>2</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050073">
<title>The ability to pick biotech talent: Being a better interviewer moves &#8216;you&#8217; up the ladder</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050073</link>
<dc:title>The ability to pick biotech talent: Being a better interviewer moves &#8216;you&#8217; up the ladder</dc:title>
<dc:creator>David G Jensen</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050073</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 13 ()</dc:source>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>13</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050072">
<title>How the UN's anti-biotech policies worsen global warming</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050072</link>
<dc:title>How the UN's anti-biotech policies worsen global warming</dc:title>
<dc:creator>Henry I Miller</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050072</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 17 ()</dc:source>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>17</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050076">
<title>Building a conducive environment for life science-based entrepreneurship and industry clusters</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050076</link>
<dc:title>Building a conducive environment for life science-based entrepreneurship and industry clusters</dc:title>
<dc:creator>Mark J Ahn</dc:creator>
<dc:creator>Michael Meeks</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050076</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 20 ()</dc:source>
<dc:date>November 27, 2007</dc:date>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:publicationDate>November 27, 2007</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>20</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050077">
<title>Cloning an industry: Strategy typologies of Shanghai biotechnology companies</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050077</link>
<dc:title>Cloning an industry: Strategy typologies of Shanghai biotechnology companies</dc:title>
<dc:creator>Ken Malone</dc:creator>
<dc:creator>Brent Hales</dc:creator>
<dc:creator>Justin Chan</dc:creator>
<dc:creator>Monica Love</dc:creator>
<dc:creator>Jeremiah Rayner</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050077</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 31 ()</dc:source>
<dc:date>November 27, 2007</dc:date>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:publicationDate>November 27, 2007</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>31</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050079">
<title>Biotechnology in India: Public&#8211;private partnerships</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050079</link>
<dc:title>Biotechnology in India: Public&#8211;private partnerships</dc:title>
<dc:creator>Viren Konde</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050079</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 43 ()</dc:source>
<dc:date>November 27, 2007</dc:date>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:publicationDate>November 27, 2007</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>43</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050080">
<title>Biogenerics 2007: How far have we come?</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050080</link>
<dc:title>Biogenerics 2007: How far have we come?</dc:title>
<dc:creator>John Tucker</dc:creator>
<dc:creator>Seth Yakatan</dc:creator>
<dc:creator>Stan Yakatan</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050080</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 56 ()</dc:source>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>56</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050081">
<title>Monoclonal antibody therapeutics: Leading companies to maximise sales and market share</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050081</link>
<dc:title>Monoclonal antibody therapeutics: Leading companies to maximise sales and market share</dc:title>
<dc:creator>Karl Ziegelbauer</dc:creator>
<dc:creator>David R Light</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050081</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 65 ()</dc:source>
<dc:date>November 27, 2007</dc:date>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:publicationDate>November 27, 2007</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>65</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050082">
<title>Globalising clinical development in Japan</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050082</link>
<dc:title>Globalising clinical development in Japan</dc:title>
<dc:creator>Yorozu Tabata</dc:creator>
<dc:creator>Chris Albani</dc:creator>
<dc:creator/>
<dc:identifier>doi:10.1057/palgrave.jcb.3050082</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 73 ()</dc:source>
<dc:date>November 27, 2007</dc:date>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:publicationDate>November 27, 2007</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>73</prism:startingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1057/palgrave.jcb.3050075">
<title>Legal and regulatory update</title>
<link>http://dx.doi.org/10.1057/palgrave.jcb.3050075</link>
<dc:title>Legal and regulatory update</dc:title>
<dc:identifier>doi:10.1057/palgrave.jcb.3050075</dc:identifier>
<dc:source>Journal of Commercial Biotechnology 14, 79 ()</dc:source>
<prism:publicationName>Journal of Commercial Biotechnology</prism:publicationName>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<prism:startingPage>79</prism:startingPage>
</item>
</rdf:RDF>
